X
Xiaogang Liu
Researcher at National University of Singapore
Publications - 605
Citations - 54443
Xiaogang Liu is an academic researcher from National University of Singapore. The author has contributed to research in topics: Medicine & Photon upconversion. The author has an hindex of 94, co-authored 425 publications receiving 41825 citations. Previous affiliations of Xiaogang Liu include Heilongjiang University & Massachusetts Institute of Technology.
Papers
More filters
Journal ArticleDOI
Cross-cultural adaptation and validation of the Chinese version of the Spine Oncology Study Group Outcomes Questionnaire
TL;DR: Wang et al. as mentioned in this paper verified and validated the Chinese version of the SOSGOQ and reported on the HRQoL of Chinese patients with spinal metastases using a single-center, prospective, observational cross-sectional study.
High-Efficiency Millimeter-Wave CMOS Oscillator Design Using Port Voltage/Current Optimization and T-Embedding Networks
TL;DR: In this article , an optimization-based design methodology for high-power and high-efficiency millimeter-wave fundamental oscillators in CMOS was presented, which can produce the final design in a single pass of optimization with a fast and robust convergence profile.
Journal ArticleDOI
MicroRNA-34a-5p promotes the progression of osteoarthritis secondary to developmental dysplasia of the hip by restraining SESN2-induced autophagy.
Jun Wang,XiaoPeng Li,Xiang Guo,Cong Wang,Zezhong Liu,Xiaogang Liu,Yan-shan Sun,Xiaohua Chen,Yimin Zhang,Gaoyang Chen +9 more
TL;DR: Wang et al. as discussed by the authors showed that miR-34a-5p could significantly inhibit the expression of SESN2, thereby promoting the activity of the mTOR signaling pathway.
Journal ArticleDOI
Retracted and Republished from: “Gut Microbiota Mediates the Therapeutic Effect of Monoclonal Anti-TLR4 Antibody on Acetaminophen-Induced Acute Liver Injury in Mice”
Xuewei Sun,Qian Cui,Juan Ni,Xiaogang Liu,Jin Zhu,Tingting Zhou,Huaying Huang,Ke Ouyang,Yulong Wu,Zhan Yang +9 more
TL;DR: Zhang et al. as mentioned in this paper developed a novel monoclonal anti-Toll-like receptor 4 (TLR4) antibody (ATAB) and hypothesized that it has therapeutic effects on APAP-induced acute liver injury and that the gut microbiota may be involved in the underlying mechanism of ATAB treatment.
Journal ArticleDOI
Characteristics of Gut Microbiota in Female Patients with Diabetic Microvascular Complications
TL;DR: Logistic regression analysis showed that after adjusting for confounding factors such as age, body mass index, family history, HbA1c, hypertension, dyslipidemia, and creatinine, Bacteroides remained an independent risk factor in female patients with DMC.